"BioVeda's creative insight and support were vital to our successful establishment of a Singapore-based subsidiary. We look forward to a long and productive relationship and to working together on additional innovative strategies to bring novel therapeutics to Asian markets."
Dr Dino Dina, President & CEO, Dynavax Technologies (NASDAQ: DVAX)
"BioVeda was the co-lead on a critical 2002 private placement for Idun. That financing provided the funds to launch a broad clinical development program for our lead drug in viral hepatitis. Since this disease is highly prevalent in Asia, the BioVeda team has played an important roll in helping Idun make the proper contacts to facilitate the clinical development of our drug locally. I can always count on the BioVeda team to provide us with expert advice!"
Dr Steven Mento, President & CEO, Idun Pharmaceuticals (acquired by Pfizer in Feb 2005)